
Creating R&D Incentives for Medicines for Neglected Diseases
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
Virtually no research is targeted at developing medicines for tropical diseases as the expected market returns from R&D into these diseases in the private pharmaceuticals sector are too low. Frank Müller-Langer addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of short-term access to affordable medicines in poor countries. The author analyzes additional push and pull mechanisms to stimulate R&D for pharmaceutical products alongside patent protection which may help mitigate the problem of those consumers in poor countries who lack access to affordable medicines. Furthermore, he reasons that a global regime of banning parallel trade from low-income countries to high-income countries is desirable from a developing country's perspective. von Müller-Langer, Frank und Behrens, Peter und Eger, Thomas und Holler, Manfred und Ott, Claus und Schäfer, Hans-Ber
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
:Dr. Frank Müller-Langer is a research fellow at the Max Planck Institute for Intellectual Property, Competition and Tax Law and academic coordinator of the International Max Research School for Competition and Innovation in Munich. He obtained his doctorate in economics from Hamburg University in 2008.
- Gebunden
- 297 Seiten
- Erschienen 2015
- De Gruyter
- hardcover
- 359 Seiten
- Erschienen 2005
- CRC Press Inc
- hardcover
- 606 Seiten
- Erschienen 2006
- Wiley-VCH
- Gebunden
- 386 Seiten
- Erschienen 2012
- Wiley-VCH
- Kartoniert
- 205 Seiten
- Erschienen 2017
- Nomos
- Hardcover
- 480 Seiten
- Erschienen 2014
- John Wiley & Sons Inc
- Kartoniert
- 212 Seiten
- Erschienen 2022
- medhochzwei
- Hardcover -
- Erschienen 2011
- Wiley-Blackwell
- Taschenbuch
- 171 Seiten
- Erschienen 2008
- WORLD HEALTH ORGN